SCHEMBL8868549

SCHEMBL8868549

CCOCCCNC(=O)c1ccc(S(=O)(=O)NC(=O)c2ccc(C(=O)NCCOC)nc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
P4HTM Q9NXG6 2/20 0.50
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
KMT2A Q03164 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 3/20 0.46
MAPT P10636 1/20 0.46
MEN1 O00255 1/20 0.45
LMNA P02545 1/20 0.44
MAPK1 P28482 1/20 0.44
EGFR P00533 2/20 0.43
NAMPT P43490 1/20 0.42
HTT P42858 1/20 0.41
EGLN1 Q9GZT9 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8867931 0.96 HPGD (0.51) HPGDSMN1; SMN2P4HTMRAB9ANPC1
SCHEMBL8869667 0.95 P4HTM (0.53) HPGDSMN1; SMN2P4HTMRAB9ANPC1
SCHEMBL8868196 0.95 P4HTM (0.53) HPGDSMN1; SMN2P4HTMRAB9ANPC1
SCHEMBL8869009 0.93 HPGD (0.50) HPGDSMN1; SMN2P4HTMRAB9ANPC1
SCHEMBL8869631 0.92 P4HTM (0.53) HPGDSMN1; SMN2P4HTMRAB9ANPC1
SCHEMBL8868459 0.92 HPGD (0.48) HPGDSMN1; SMN2P4HTMRAB9ANPC1
SCHEMBL9140136 0.91 HPGD (0.52) HPGDSMN1; SMN2P4HTMRAB9ANPC1
SCHEMBL8869333 0.91 P4HTM (0.48) HPGDSMN1; SMN2P4HTMRAB9ANPC1
SCHEMBL8869116 0.91 P4HTM (0.53) HPGDP4HTMKMT2AL3MBTL1ALDH1A1
SCHEMBL8869962 0.91 P4HTM (0.58) HPGDSMN1; SMN2P4HTMRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed